End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.96 CNY | -9.99% | +31.82% | -4.19% |
06:22am | China stocks rise as strength in banks offsets developers' falls | RE |
Jan. 03 | Tranche Update on Zhejiang Shengda Bio-Pharm Co., Ltd.'s Equity Buyback Plan announced on May 9, 2023. | CI |
Sales 2021 | 790M 109M | Sales 2022 | 738M 102M | Capitalization | 2.15B 298M |
---|---|---|---|---|---|
Net income 2021 | 75M 10.39M | Net income 2022 | 31M 4.29M | EV / Sales 2021 | 3.27 x |
Net cash position 2021 | 378M 52.3M | Net cash position 2022 | 288M 39.89M | EV / Sales 2022 | 2.52 x |
P/E ratio 2021 |
39.3
x | P/E ratio 2022 |
69.7
x | Employees | 1,152 |
Yield 2021 |
0.81% | Yield 2022 |
0.48% | Free-Float | 42.01% |
1 day | -9.99% | ||
1 week | +31.82% | ||
Current month | +45.42% | ||
1 month | +46.64% | ||
3 months | -3.66% | ||
6 months | +4.57% | ||
Current year | -4.19% |
Managers | Title | Age | Since |
---|---|---|---|
Bin Zhou
CEO | Chief Executive Officer | 58 | 13-12-12 |
Xiang Xiao Xu
DFI | Director of Finance/CFO | 44 | 22-04-26 |
Jing Zhu
BRD | Director/Board Member | 38 | 11-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bu Fei Chen
BRD | Director/Board Member | 64 | 13-09-23 |
Xi Qin Chen
BRD | Director/Board Member | 59 | 19-12-17 |
Yong Quan Li
BRD | Director/Board Member | 62 | 21-09-16 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 13.96 | -9.99% | 26,258,370 |
24-03-27 | 15.51 | +10.00% | 1,091,726 |
24-03-26 | 14.1 | +9.98% | 5,163,849 |
24-03-25 | 12.82 | +10.04% | 8,265,658 |
24-03-22 | 11.65 | +10.01% | 5,204,415 |
End-of-day quote Shanghai S.E., March 27, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-4.19% | 330M | |
+6.08% | 7.73B | |
-1.30% | 7.12B | |
+1.75% | 6.04B | |
-2.11% | 3.92B | |
-14.07% | 3.4B | |
-5.45% | 1.3B | |
-9.51% | 933M | |
+4.04% | 906M | |
-15.98% | 816M |